Les Sulewski
Stock Analyst at Truist Securities
(1.09)
# 3,840
Out of 5,090 analysts
14
Total ratings
53.85%
Success rate
-15.75%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Les Sulewski
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PCRX Pacira BioSciences | Maintains: Buy | $30 → $28 | $24.00 | +16.69% | 7 | Nov 7, 2025 | |
| COLL Collegium Pharmaceutical | Maintains: Buy | $45 → $48 | $47.91 | +0.19% | 3 | Nov 7, 2025 | |
| TEVA Teva Pharmaceutical Industries | Initiates: Buy | $25 | $28.46 | -12.16% | 1 | May 28, 2025 | |
| AMRX Amneal Pharmaceuticals | Maintains: Buy | $10 → $12 | $12.18 | -1.48% | 3 | Oct 2, 2024 |
Pacira BioSciences
Nov 7, 2025
Maintains: Buy
Price Target: $30 → $28
Current: $24.00
Upside: +16.69%
Collegium Pharmaceutical
Nov 7, 2025
Maintains: Buy
Price Target: $45 → $48
Current: $47.91
Upside: +0.19%
Teva Pharmaceutical Industries
May 28, 2025
Initiates: Buy
Price Target: $25
Current: $28.46
Upside: -12.16%
Amneal Pharmaceuticals
Oct 2, 2024
Maintains: Buy
Price Target: $10 → $12
Current: $12.18
Upside: -1.48%